Craif and Hokkaido University Graduate School of Medicine Started a New Joint Study for Gynecological Cancers
Craif Was Featured in the CRDS Research Report as a Major Biotech Startup in Japan
Craif and Nagoya University Hospital Started a New Joint Study for Ovarian Cancer and Other Gynecological Cancers
Craif Expanded Research Lab at Nagoya University’s NIC Building and Opens “Craif NU Nanodevice Joint Research Division,” an Industry-Academia Collaboration Research Chair
Dr. Ichikawa, CTO of Craif, Made a Presentation at the 81st Discussion Session of the Japan Society for Analytical Chemistry
Craif Began a Joint Study with Nissin Foods to Establish a New Analytical Method for “Disease Prevention” Using Urinary miRNA Analysis
Craif Presented the Results of Urine-based Urothelial Cancer Detection Research at the American Association of Cancer Research (AACR) Annual Meeting 2021
Craif Announced Its Residency at JLABS @ Shanghai To Further Accelerate the Development of an Innovative Exosome Biomarker Discovery Platform
Ryuichi Onose, CEO of Craif, Has Been Selected as “Forbes 30 Under 30 Asia 2021” in the Healthcare & Science Field
Research Article on Brain Tumor Detection from Urinary microRNA was Published